Navigation Links
Parkinson's Institute research shows that nicotine reduces levodopa-induced dyskinesias
Date:10/24/2007

SUNNYVALE, Calif., October 24, 2007 The Parkinsons Institute and Clinical Center today announced research showing that intermittent nicotine treatment reduces medication-induced dyskinesias by as much as 50 percent in models of Parkinsons disease. Lead by senior research scientist, Maryka Quik, Ph.D., the research will be published in an upcoming issue of the Annals of Neurology.

Levodopa, the most common drug used to treat Parkinsons disease, is initially very effective. However, long-term treatment often lessens efficacy and causes multiple complications, including abnormal involuntary movements, called dyskinesias. These uncontrolled movements of the head and limbs tend to worsen over time and can become as debilitating as Parkinsons disease itself. Currently, there are only limited therapeutic options for dyskinesias, including reduction in levodopa dose, amantadine administration, and deep brain stimulation for a limited number of patients.

Most of the research on tobacco has focused on its detrimental health effects. Studies conducted over the last 40 years show that the incidence of Parkinsons disease is about 50 percent less in smokers than in the general population. Recent studies in experimental models suggest that the nicotine in smoke may be responsible for this neuroprotective effect. In addition, this is the first research to show that nicotine may also reduce levodopa-induced dyskinesias. With an estimated 1.5 million Parkinsons disease patients in the United States, and levodopa being the top prescribed medication for Parkinsons disease, this study has far-reaching implications for the treatment of Parkinsons disease.

Our hope is that this research represents a useful treatment strategy to reduce the dyskinesias that so many Parkinsons disease patients suffer, said Dr. Maryka Quik of the Parkinsons Institute and Clinical Center in Sunnyvale. Reducing the side effects of levodopa makes it a much more effective and long-term treatment.


'/>"/>

Contact: Alicia Swanson
alicia.swanson@comcast.net
408-836-7170
The Parkinson's Institute
Source:Eurekalert

Related medicine news :

1. Gambling related to Parkinsons medication
2. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
3. Highly Educated More Prone To Parkinsons Disease
4. Make Treatment of Parkinsons More Affordable, Doctors Plead
5. Parkinsons Disease can Be Predicted by Metabolic Pathway
6. Neural Stem Cells Reduce Parkinsons Symptoms in Monkeys
7. Risk of Parkinsons Increased by Exposure to Pesticide and Head Trauma
8. Coenzyme Q10 Does Not Improve Parkinsons Disease Symptoms
9. Patients Affected by Parkinsons may Be Benefited from Treadmill Exercise
10. UCLA Researchers Discover Link Between Parkinsons and Narcolepsy
11. First Ever Patch Drug To Treat Parkinsons Symptoms Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: